Viridian Therapeutics Inc (NASDAQ: VRDN) established initial surge of 12.61% at $27.5, as the Stock market unbolted on thursday, before settling in for the price of $24.42 at the close. Taking a more long-term approach, VRDN posted a 52-week range of $9.90-$27.20.
It was noted that the giant of the Healthcare sector posted annual sales growth of 31.28% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 31.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.36%. This publicly-traded company’s shares outstanding now amounts to $93.09 million, simultaneously with a float of $83.85 million. The organization now has a market capitalization sitting at $2.56 billion. At the time of writing, stock’s 50-day Moving Average stood at $21.12, while the 200-day Moving Average is $16.93.
Viridian Therapeutics Inc (VRDN) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Viridian Therapeutics Inc industry. Viridian Therapeutics Inc’s current insider ownership accounts for 9.93%, in contrast to 94.03% institutional ownership. According to the most recent insider trade that took place on Oct 23 ’25, this organization’s Director bought 454,545 shares at the rate of 22.00, making the entire transaction reach 9,999,990 in total value, affecting insider ownership by 3,914,458.
Viridian Therapeutics Inc (VRDN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.17 per share during the current fiscal year.
Viridian Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 5.36% and is forecasted to reach -3.44 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 23.17% through the next 5 years, which can be compared against the 31.28% growth it accomplished over the previous five years trading on the market.
Viridian Therapeutics Inc (NASDAQ: VRDN) Trading Performance Indicators
Let’s observe the current performance indicators for Viridian Therapeutics Inc (VRDN). It’s Quick Ratio in the last reported quarter now stands at 11.28. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 36.16.
In the same vein, VRDN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.53, a figure that is expected to reach -0.96 in the next quarter, and analysts are predicting that it will be -3.44 at the market close of one year from today.
Technical Analysis of Viridian Therapeutics Inc (VRDN)
Now, what If we examine the latest scores posted by [Viridian Therapeutics Inc, VRDN]. During the last 5-days, its volume was better the volume of 0.96 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 69.11% While, its Average True Range was 78.08.
Raw Stochastic average of Viridian Therapeutics Inc (VRDN) in the period of the previous 100 days is set at 92.55%, which indicates a major rise in contrast to 84.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.35 that was higher than 1.00 volatility it exhibited in the past 100-days period.
